The Global Market for Big Data Technologies and Services is Projected to Reach $60 Billion by 2022

The global market for Compression Therapy is projected to reach US$3.3 billion by 2025, driven by the rising incidence of venous ulcers supported by aging population and the obesity epidemic. Weak blood circulation in the limbs and malfunctioning venous valves due to leg injury/surgery; obesity; prolonged periods without movement and blood clots in veins, are chief causes of venous ulcers. If left untreated, chronic venous disorders can result in the development of dilated veins also known as “spider veins.” Compression therapy represents the first line of treatment for venous ulcers and is aimed at increasing blood flow to lower limbs and extremities by simple application of gentle pressure.  Few of the benefits of this therapy include muscle compression to mobilize blood flow and fight inflammation and edema; reduced muscle soreness; helps loosen up the veins; relives pain by reducing lactic acid build-up in muscles; restores valve competence; reduces venous reflux (VR); accelerates capillary flow, and lowers capillary fluid leakage. Properly designed compression products also help soften lipodermatosclerosis and improve lymphatic flow. Compression stockings, stretch wraps, bandages and socks are popular types of compression products. Growing focus shed on product design is poised to benefit demand for medical compression hosiery. Also poised to benefit the market is the development of medical grade compression standards which are calibrated to be 20 mmHg (millimeters of mercury) and over to encourage muscle oxygenation and prevent tissue damage, injury to skin, constriction, thrombosis, and local damage to the peroneus and peripheral nerves resulting from wrong compression pressure.  Read More…